# DEXAMETHASONE SODIUM PHOSPHATE

NDC: 51662-1297
Generic name: DEXAMETHASONE SODIUM PHOSPHATE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRAVENOUS, SOFT TISSUE
Marketing started: 20190721

FDA application: ANDA084282

## Active ingredients

- DEXAMETHASONE SODIUM PHOSPHATE: 4 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1297"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1297
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e36534f-d64c-7e7b-e053-2995a90ad48e